Pathology
 |
|
30 september 2017 21:03:24 |
| A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks` observational data (BMC Infectious Diseases) |
|
Tweet Dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) is a simple combination of drugs that has the best genetic barrier to HIV-1 resistance and may be fit for salvage therapy. |
| 168 viewsCategory: Immunology, Pathology |
 Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study (BMC Infectious Diseases)Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis? (BMC Infectious Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
